Skip to main content
. 2015 Oct 5;34(2):123–129. doi: 10.1200/JCO.2015.62.0138

Table A2.

Survival Groups

No. of Prognostic Factors* 2-Year OS (%) Median Survival (months) P
0 33 5.5 < .001
1 59 NR < .001
2 76 42.7 < .001
3 100 NR < .001

Abbreviations: NR, not reached; OS, overall survival.

*

Prognostic factors included Karnofsky performance score 90 to 100, no extracranial metastasis, and tyrosine kinase inhibitor initiated after brain metastasis.